Home » PROTAGEN AG CLOSES SECOND ROUND OF FINANCING WITH OLD AND NEW INVESTORS
PROTAGEN AG CLOSES SECOND ROUND OF FINANCING WITH OLD AND NEW INVESTORS
The MIG AG Funds 1 and 3 in Munich are investing into Protagen AG. In cooperation with the co-investor S-Venture Capital Dortmund GmbH, EUR 3,3 Million will be invested into Protagen AG. Protagen AG has successfully switched from a fee-for-service company to a product company. CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=593245)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May